Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization


Huang R. S. P. , Smith D., Le C. H. , Liu W., Ordinario E., Manohar C., ...More

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, vol.144, no.6, pp.735-741, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 144 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.5858/arpa.2019-0085-oa
  • Journal Name: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index
  • Page Numbers: pp.735-741
  • Istanbul University Affiliated: Yes

Abstract

Context.-The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.